Literature DB >> 24393943

[A case of liver metastasis from esophageal cancer treated with stereotactic body radiation therapy].

Tomohisa Egawa1, Yusuke Okubo, Takeshi Kemmochi, Takayuki Mori, Shinji Sato, Shin Nishiya, Koki Mihara, Yasuhiro Ito, Hiroyuki Makino, Atsushi Nagashima.   

Abstract

A 70-year-old woman was diagnosed as having advanced lower thoracic esophageal cancer with abdominal lymph node metastases(T3N1M0, Stage III). After administering 2 courses of neoadjuvant chemotherapy with 5-fluorouracil(5- FU)( 800 mg/m2)and cisplatin(80 mg/m2), we performed curative surgery with D2 lymph node dissection. The patient could not receive adjuvant chemotherapy because of her poor performance status. After curative surgery, liver metastasis appeared in segment 8. The liver metastasis(S8)was treated with stereotactic body radiation therapy(SBRT)( 60 Gy/3 Fr). After SBRT, we administered systemic chemotherapy with docetaxel and nedaplatin as second-line chemotherapy. The patient had no recurrence for 12 months after SBRT. SBRT exhibited an excellent local therapeutic effect without any serious complications, suggesting that it is an effective treatment for liver metastasis from esophageal cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24393943

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  3 in total

1.  Stereotactic body radiotherapy for oligo-recurrence in the liver in a patient with esophageal carcinoma: A case report.

Authors:  Atsuto Katano; Hideomi Yamashita; Keiichi Nakagawa
Journal:  Mol Clin Oncol       Date:  2017-10-04

2.  Image-guided interstitial high-dose-rate brachytherapy in the treatment of metastatic esophageal squamous cell carcinoma.

Authors:  Jazan Omari; Constanze Heinze; Antje Wilck; Peter Hass; Max Seidensticker; Robert Damm; Katharina Fischbach; Jens Ricke; Maciej Pech; Maciej Powerski
Journal:  J Contemp Brachytherapy       Date:  2018-10-23

3.  Hepatic Metastasis in Newly Diagnosed Esophageal Cancer: A Population-Based Study.

Authors:  Huawei Li; Shengqiang Zhang; Jida Guo; Linyou Zhang
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.